Nasdaq

Autonomix Medical Achieves Design Lock for Apex 6 Radiofrequency Generator, Advances Towards U.S. Clinical Trials for Pancreatic Cancer Pain Treatment

Autonomix Medical completes design enhancements for the Apex 6 RF Generator, advancing clinical trial plans for pancreatic cancer pain treatment. Autonomix Medical, Inc. has announced a significant ...
Nasdaq

Autonomix Enters into Definitive Agreement to License Intellectual Property for FDA-Cleared Ablation Technology from RF Innovations, Inc.

THE WOODLANDS, TX, July 15, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to ...